• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » 3M sues Florida company for alleged mask price-gouging

3M sues Florida company for alleged mask price-gouging

April 15, 2020 By Nancy Crotti

3M3M (NYSE:MMM) has sued a Florida company for allegedly trying to sell tens of millions of the company’s N95 respirators to the federal government at inflated prices.

The lawsuit filed in the U.S. District Court for the Northern District of Florida alleges that Orlando-based Geftico LLC twice attempted to fraudulently sell the “likely nonexistent” respirators at “grossly inflated prices” to the strategic national stockpile while falsely affiliating itself with 3M.

The U.S. Centers for Disease Control and Prevention notified 3M that Geftico made the offers in March and April, according to Maplewood, Minn.-based 3M. The company said it confirmed that Geftico was not affiliated with it and that such a quantity of 3M respirators did not exist.

Geftico also falsely blamed the prices on 3M, claiming that 3M had changed prices “several times” in just a few days when 3M has not changed the prices it charges for respirators, 3M claims. The company is seeking an injunction to make Geftico stop its allegedly illegal activities and wants the company to pay damages, which 3M said it will donate to COVID-19-related nonprofit organizations.

Geftico could not be reached for comment.

The lawsuit is the fourth filed recently by 3M against companies it claims have engaged in price-gouging and counterfeiting. The company said it is working with national and international law enforcement, state attorneys general, and with online retailers and technology companies such as Google, Amazon and Facebook to identify and remove counterfeiters and price gougers from their sites and refer them to law enforcement authorities.

In the other three lawsuits, filed April 10, the company alleges that:

  • New Jersey-based Performance Supply falsely claimed a business affiliation with 3M and offered to sell $45 million worth N95 respirators to New York City government officials at inflated prices.
  • Utah-based Rx2Live falsely claimed to be a 3M distributor and offered millions of N95 respirators at inflated prices to healthcare provider Community Medical Centers (Fresno, Calif.).
  • A John Doe defendant in Irving Texas falsely claimed to be a “3M Company Trust Account” able to sell millions of 3M-brand N95 respirators at inflated prices to New York City government officials.

“3M will continue to take action against those who exploit the demand for N95 respirators used by healthcare workers on the frontlines of the COVID-19 fight,” said 3M SVP for corporate affairs Denise Rutherford in a news release. “We will continue to work with state, federal and international law enforcement to root out illegal behavior and put a stop to it.”

N95 respirators have been in short supply since the COVID-19 pandemic started. Some of the earliest reports of shortages in the U.S. occurred in early March. Since then, 3M has ramped up production of its face masks, making 1.1 billion annually with 400 million in the U.S., and has partnered with Ford to make its powered air-purifying respirators.

Filed Under: Featured, Legal News, Respiratory Tagged With: 3m, Alphabet (Google), Amazon, coronavirus, COVID-19, Facebook

More recent news

  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
  • GE HealthCare launches new MRI scanner
  • HistoSonics earns first major reimbursement win for non-invasive histotripsy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy